Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: The pediatric OCD treatment study II (POTS II) randomized controlled trial

JAMA

Volumn 306, Issue 11, 2011, Pages 1224-1232

  Franklin, Martin E ^a   Sapyta, Jeffrey ^b   Freeman, Jennifer B ^c   Khanna, Muniya ^a   Compton, Scott ^b   Almirall, Daniel ^d   Moore, Phoebe ^e   Choate Summers, Molly ^c   Garcia, Abbe ^c   Edson, Aubrey L ^a   Foa, Edna B ^a   March, John S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 80053090173     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1344     Document Type: Article

References (34)

1. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
2. Piacentini J, Bergman RL. Obsessive-compulsive disorder in children. Psychiatr Clin North Am. 2000;23(3):519-533. (Pubitemid 30666504)
3. Piacentini J, Bergman RL, Keller M, McCracken J. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2003;13(suppl 1):S61-S69. (Pubitemid 36886095)
4. Swedo SE, Rapoport JL, Leonard HL, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents: clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry. 1989;46(4):335-341. (Pubitemid 19111487)
5. Watson HJ, Rees CS. Meta-analysis of randomized, controlled treatment trials for pediatric obsessivecompulsive disorder. J Child Psychol Psychiatry. 2008;49(5):489-498. (Pubitemid 351503099)
6. Abramowitz JS, Whiteside SP, Deacon BJ. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther. 2005;36(1):55-63. (Pubitemid 43150332)
7. PediatricOCDTreatment Study (POTS) Team. Cognitive- behavior therapy, sertraline, and their combination for children and adolescents with obsessivecompulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969-1976.
8. March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA. 1998;280(20):1752-1756. (Pubitemid 28536875)
9. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessivecompulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2):222-229. (Pubitemid 32111026)
10. Simpson HB, Foa EB, Liebowitz MR, et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessivecompulsive disorder. Am J Psychiatry. 2008;165(5):621-630. (Pubitemid 351705340)
11. Freeman JB, Choate-Summers ML, Garcia AM, et al. The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods. Child Adolesc Psychiatry Ment Health. 2009;3:1-15.
12. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. (Pubitemid 19278229)
13. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844-852. (Pubitemid 27250450)
14. Silverman W, Albano A. The Anxiety Disorders Interview Schedule for DSM-IV, Child and Parent Versions. San Antonio, TX: Psychological Corp; 1996.
15. March J, Mulle K. OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual. New York, NY: Guilford Press; 1998.
16. Silverman WK, Saavedra LM, Pina AA. Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry. 2001;40(8):937-944. (Pubitemid 32667077)
17. Tolin DF, Abramowitz JS, Diefenbach GJ. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale. J Clin Psychiatry. 2005;66(12):1549-1557. (Pubitemid 43068694)
18. Conners C, March J. The Conners/March Developmental Questionnaire. Toronto, ON: MultiHealth Systems Inc; 1996.
19. Guy W, Bonato R, eds. CGI: Clinical Global Impressions. Chevy Chase, MD: National Institute of Mental Health; 1970.
20. March J, Karayal O, Chrisman A. CAPTN: The Pediatric Adverse Event Rating Scale. Presented at: the Scientific Proceedings of the 2007 Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 23-28, 2007; Boston, MA. No. 241.
21. The R project for statistical computing. Institute for Statistics and Mathematics Resources Web site. R: A language and environment for statistical computing. http://www.R-project.org. Accessed.
22. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley & Sons; 1987:258.
23. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Slenberger P. Amultivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27:85-95.
24. Miller RG. Simultaneous Statistical Inference. New York, NY: McGraw-Hill; 1966.
25. Barnard J, Rubin DB. Small-sample degrees of freedom with multiple imputation. Biometrika. 1999;86(4):948-955.
26. Allison PD. SAS Macros. http://www.pauldallison.com/Download3.html. Updated June 14, 2011. Accessed June 14, 2011.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum Associates; 1988.
28. Williams M, Powers M, Yun YG, Foa EB. Minority participation in randomized controlled trials for obsessive-compulsive disorder. J Anxiety Disord. 2010;24(2):171-177.
29. Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol. 2000;68(4):594-602.
30. Tenneij NH, Van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry. 2005;66(9):1169-1175. (Pubitemid 41442285)
31. Rothbaum BO, Shahar F. Behavioral treatment of obsessive-compulsive disorder in a naturalistic setting. Cognit Behav Pract. 2000;7:262-270.
32. Warren R, Thomas JC. Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: an effectiveness study. J Anxiety Disord. 2001;15(4):277-285. (Pubitemid 32594865)
33. Nakatani E, Mataix-Cols D, Micali N, Turner C, Heyman I. Outcomes of cognitive behaviour therapy for obsessive compulsive disorder in a clinical setting: a 10-year experience from a specialist OCD service for children and adolescents. Child Adolesc Ment Health. 2009;14(3):133-139.
34. Valderhaug R, Larsson B, Götestam KG, Piacentini J. An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessivecompulsive disorder administered in regular outpatient clinics. Behav Res Ther. 2007;45(3):577-589. (Pubitemid 46156930)